Related Experiment Video
Updated: Aug 22, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast
Tiziano Baroni1, Paolo Carinci, Cinzia Lilli
1Institute of Histology and General Embryology, University of Perugia, Perugia, Italy.
Abstract:
Unregulated fibroblast growth factor 2 (FGF2) signaling caused by mutations in the fibroblast growth factor receptor (FGFR2) leads to human craniosynostosis such as the Apert syndrome. In an in vitro control model of calvarial osteoblasts from Apert patients carrying the FGFR2 P253R mutation, we studied the changes in cellular phenotype and evaluated the effects of FGF2. Compared with wild-type controls, osteocalcin mRNA was down-regulated in Apert osteoblasts, Runt-related transcription factor-2 (RUNX2) mRNA was differentially spliced, and FGF2 secretion was greater. Total protein synthesis, fibronectin and type I collagen secretion were up-regulated, while protease and glycosidase activities and matrix metalloproteinase-13 (MMP-13) transcription were decreased, suggesting an altered ECM turnover. Adding FGF2 increased protease and glycosidase activities and down-regulated fibronectin and type I collagen secretion in Apert osteoblasts. High affinity FGF2 receptors were up-regulated in Apert osteoblasts and analysis of signal transduction showed elevated levels of Grb2 tyrosine phosphorylation and the Grb2-p85 beta association, which FGF2 stimulation strongly reduced. All together these findings suggest increased constitutive receptor activity in Apert mutant osteoblasts and an autocrine loop involving the FGF2 pathway in modulation of Apert osteoblast behavior.
Insights
Fibroblast growth factor receptor 2 (FGFR2) mutations in Apert syndrome lead to altered osteoblast function. FGF2 signaling is dysregulated, impacting extracellular matrix turnover and cell behavior.
Area of Science:
- Molecular biology
- Cell biology
- Genetics
Background:
- Fibroblast growth factor 2 (FGF2) signaling is crucial for skeletal development.
- Mutations in fibroblast growth factor receptor 2 (FGFR2) cause craniosynostosis, including Apert syndrome.
- Understanding FGFR2 mutations' cellular effects is vital for craniosynostosis research.
Purpose of the Study:
- To investigate cellular phenotype changes in Apert patient osteoblasts.
- To evaluate the impact of FGF2 on these cells.
- To elucidate the FGF2 signaling pathway in Apert syndrome.
Main Methods:
- In vitro study using calvarial osteoblasts from Apert patients (FGFR2 P253R mutation) and wild-type controls.
- Analysis of gene expression (osteocalcin, RUNX2, MMP-13) and protein secretion (fibronectin, collagen).
- Assessment of enzyme activities, receptor expression, and signal transduction pathways (Grb2 phosphorylation).
Main Results:
- Apert osteoblasts showed down-regulated osteocalcin mRNA, altered RUNX2 splicing, and increased FGF2 secretion.
- Increased total protein synthesis and fibronectin/collagen secretion, with decreased protease/glycosidase activity and MMP-13 transcription.
- FGF2 addition modulated these changes; elevated FGF2 receptor activity and Grb2 signaling were observed, reduced by FGF2 stimulation.
Conclusions:
- Apert osteoblasts exhibit increased constitutive FGFR2 activity.
- An autocrine FGF2 loop likely modulates Apert osteoblast behavior.
- Findings provide insights into craniosynostosis pathogenesis and potential therapeutic targets.
More Related Videos
07:26Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle